亚洲 · 财经报刊 · SCMP Business
Could new US investment curbs complicate China’s biotech licensing surge?
Chinese biotech firms face fresh headwinds in their global expansion as Washington’s proposed outbound investment restrictions threaten to disrupt deal structures, even though…
在 SCMP Business 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.scmp.com)
